Articles published by SOLVD Health

SOLVD Health’s Pharmacogenomics Test Receives New York State Department of Health Approval

December 17, 2025

From SOLVD Health

Via Business Wire

SOLVD Health Publishes Peer-Reviewed Framework to Advance Clinical Use of Genomic Data

December 15, 2025

From SOLVD Health

Via Business Wire

SOLVD Health Advances Development of Novel Test to Optimize GLP-1 Therapeutic Response

December 09, 2025

From SOLVD Health

Via Business Wire

SOLVD Health Appoints Mike Aicher and Vince Cebula to Board of Directors to Support Next Phase of Growth

May 12, 2025

From SOLVD Health

Via Business Wire

SOLVD Health Receives New York State Laboratory Approval

December 24, 2024

From SOLVD Health

Via Business Wire

SOLVD Health to Present at William Blair’s Innovator Series: Life Science Tools and Diagnostics

December 10, 2024

From SOLVD Health

Via Business Wire

SOLVD Health Launches 5-Year Post-Approval Study on Real-World Impact for AvertD® Genetic Test

November 18, 2024

From SOLVD Health

Via Business Wire

SOLVD Health Receives FDA PMA Supplement Approval for Use of INFINITI High-Throughput System with AvertD®

November 12, 2024

From SOLVD Health

Via Business Wire

SOLVD Health Names Chief Financial Officer and Senior Vice President of Clinical Operations

August 13, 2024

From SOLVD Health

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.